Clinical article · Acute care

Paracetamol overdose: the nomogram, acetylcysteine regimens and the pitfalls

Written for
Hospital physicians, emergency doctors and residents
Reading time
8 minutes
Published
Updated

Written by the Sana Health team for clinicians. It summarises published guidance, is not a guideline and has not been peer reviewed. Check current local protocols before acting.

Key points

  • The nomogram applies only to a single acute ingestion at a known time, with a level taken at least 4 hours after it.
  • Treatment lines differ between countries: the UK line starts at 100 mg/L at 4 hours, the US, Australian and New Zealand lines at 150 mg/L.
  • Acetylcysteine works best when started early; a late presentation, an unknown time or a staggered ingestion is treated without waiting for a level.
  • Shorter and two-bag regimens deliver the same total dose as the three-bag regimen and appear to cause fewer adverse reactions.
  • Before stopping acetylcysteine, repeat the liver tests, INR and paracetamol level and continue if the local criteria are not met.

Why timing decides the outcome

Paracetamol poisoning is among the commonest causes of acute liver failure and of referral to transplant centres worldwide [9, 12]. Acetylcysteine, which replenishes glutathione, is highly effective when it is started early, and is most protective when given within about 8 hours of an acute ingestion; its effect falls as liver injury becomes established [1, 2]. Every step of the assessment is therefore built to avoid two errors: withholding treatment from a patient at risk, and giving an unnecessary infusion to one who is not.

National guidance differs in its detail. This article follows the common ground of the US and Canadian consensus statement [1] and the Australian and New Zealand guideline [2], and notes where UK practice differs. The local protocol and the poisons information centre take precedence.

Risk assessment

  • Dose in mg/kg of body weight, using the patient's weight and the capped dosing weight the local protocol specifies.
  • Time of ingestion, and whether it was a single acute ingestion, staggered over a longer period or repeated supratherapeutic use; consensus definitions now exist for these patterns [6].
  • Formulation: modified-release paracetamol can give a delayed or second peak.
  • Co-ingestants, especially opioids and anticholinergic drugs, which slow gastric emptying.
  • Bloods: paracetamol concentration at 4 hours or later, ALT, INR, creatinine, glucose and, if the patient is unwell or presents late, a blood gas with lactate.

Activated charcoal may be considered when the patient presents early after a large ingestion and the airway is safe; the time window used differs between guidelines [1, 11].

Using the nomogram

The treatment nomogram plots the paracetamol concentration against the hours since a single acute ingestion. Countries use different lines: the UK has used a single line starting at 100 mg/L at 4 hours for all patients since 2012, whereas the United States, Australia and New Zealand use a line starting at 150 mg/L at 4 hours [1, 2, 4]. A level above the line means acetylcysteine is indicated.

Worked example: a 58 kg woman took 16 g six hours ago; her level is 142 mg/L at 6 hours and her ALT is 38. The dose is about 276 mg/kg. Both lines fall with time, and at 6 hours the 100 line sits at about 71 mg/L and the 150 line at about 106 mg/L. Her level is above either line, so she needs acetylcysteine now, whichever nomogram the hospital uses.

Check the units. A concentration in micromol/L is about 6.6 times the same concentration in mg/L, and mg/L is the same as micrograms per mL. Plotting micromol/L on a mg/L nomogram, or the reverse, is a recognised cause of error.

Acetylcysteine regimens

All the common intravenous regimens give a total of 300 mg/kg; they differ in how fast the first dose runs. The traditional three-bag regimen front-loads a high concentration, which causes nausea, vomiting and non-allergic anaphylactoid reactions that can interrupt treatment. In the SNAP trial a 12-hour regimen with a slower first infusion caused less vomiting and fewer anaphylactoid reactions than the standard regimen [7]. The randomised evidence on interventions for paracetamol overdose has been gathered in a Cochrane review [3]. Systematic reviews of two-bag regimens suggest fewer adverse reactions with similar protection against liver injury, although most of the evidence is observational [8, 9].

RegimenInfusionsDuration
Three-bag150 mg/kg, then 50 mg/kg over 4 hours, then 100 mg/kg over 16 hoursAbout 21 hours
Two-bag (Australia and New Zealand)200 mg/kg over 4 hours, then 100 mg/kg over 16 hours20 hours
SNAP (used in parts of the UK)100 mg/kg over 2 hours, then 200 mg/kg over 10 hours12 hours

For a very large ingestion or a concentration far above the treatment line, several guidelines increase the acetylcysteine dose, and specialist toxicology advice is appropriate [1, 2, 10]. At the end of the infusion, the paracetamol concentration, ALT and INR are repeated; treatment continues if the level is still detectable or liver injury is present, by the criteria in the local protocol.

When not to wait for a level

  • Presentation more than 8 hours after a potentially toxic dose: start acetylcysteine at once, then use the level and ALT to decide whether to continue.
  • Unknown time of ingestion, or a staggered overdose: the nomogram cannot be used, so treat on the dose history.
  • Any ingestion with abnormal ALT, coagulopathy, acidosis or clinical signs of liver injury.
  • Repeated supratherapeutic ingestion, assessed by dose, symptoms, ALT and a detectable level according to the local protocol.

Signs of liver failure (worsening INR, acidosis, rising lactate, encephalopathy, renal impairment) call for early discussion with a liver unit, using the King's College criteria or the local transplant referral criteria [12]. Combined measures such as the paracetamol-aminotransferase multiplication product have been studied for risk stratification but do not replace the protocol [5].

Pitfalls

  • A level taken before 4 hours, which cannot be interpreted on the nomogram.
  • Accepting an uncertain time of ingestion as exact.
  • A modified-release preparation or an opioid co-ingestion with a single reassuring level; repeat it.
  • Unit confusion between mg/L and micromol/L.
  • Stopping the infusion on time without repeating the bloods.
  • Treating an adverse reaction as allergy and abandoning the antidote; most reactions settle when the infusion is paused and restarted more slowly.
  • Overlooking the mental health assessment and safeguarding that follow a deliberate overdose.

How Sana Health helps

Given the amount taken, the time, the weight and any level with its sampling time, the Toxicology and Poisoning engine calculates the dose per kilogram, states which nomogram line it applied and whether the patient is above it, and recognises when the nomogram cannot be used. Its antidote table gives the acetylcysteine regimen with each infusion calculated for the patient's weight, and the report sets out monitoring, stopping criteria and medical clearance, with references from PubMed and the US acetylcysteine label from DailyMed.

Questions

Can the paracetamol nomogram be used for a staggered overdose?

No. The nomogram assumes a single ingestion at a known time. Staggered ingestions, an unknown time and repeated supratherapeutic use are assessed on the dose history, liver tests and level according to the local protocol, and are usually treated.

What causes reactions to intravenous acetylcysteine?

Most are non-allergic anaphylactoid reactions related to the high concentration of the first infusion: flushing, rash, wheeze or hypotension. They usually settle when the infusion is paused, treated symptomatically and restarted more slowly.

Is acetylcysteine safe in pregnancy?

Pregnant patients are treated with acetylcysteine by the same criteria as other adults, because untreated paracetamol toxicity is the greater risk to mother and fetus. Obstetric review is part of the plan.

References

  1. Management of Acetaminophen Poisoning in the US and Canada: A Consensus Statement (opens in a new tab)JAMA Netw Open, 2023
  2. Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand (opens in a new tab)Med J Aust, 2020
  3. Interventions for paracetamol (acetaminophen) overdose (opens in a new tab)Cochrane Database Syst Rev, 2018
  4. Criteria for acetylcysteine treatment and clinical outcomes after paracetamol poisoning (opens in a new tab)Expert Rev Clin Pharmacol, 2012
  5. Performance of the paracetamol-aminotransferase multiplication product in risk stratification after paracetamol (acetaminophen) poisoning: a systematic review and meta-analysis (opens in a new tab)Clin Toxicol (Phila), 2023
  6. Paracetamol (acetaminophen) poisoning; consensus definitions of poisoning types and outcomes to be used in the clinical toxicology recommendations collaborative systematic review (opens in a new tab)Clin Toxicol (Phila), 2025
  7. Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial (opens in a new tab)Lancet, 2014
  8. Is Two Better Than Three? A Systematic Review of Two-bag Intravenous N-acetylcysteine Regimens for Acetaminophen Poisoning (opens in a new tab)West J Emerg Med, 2023
  9. Comparison of two-bag and three-bag acetylcysteine regimens in the treatment of paracetamol poisoning: a systematic review and meta-analysis (opens in a new tab)Clin Toxicol (Phila), 2025
  10. What is the most appropriate dose of N-acetylcysteine after massive acetaminophen overdose? (opens in a new tab)Clin Toxicol (Phila), 2019
  11. Recommendations from the Clinical Toxicology Recommendations Collaborative on the administration of activated charcoal in acute oral overdose (opens in a new tab)Clin Toxicol (Phila), 2026
  12. Acute liver failure (opens in a new tab)Lancet, 2019